Bridgeway Capital Management’s Utah Medical Products UTMD Stock Holding History

Bridgeway Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$310K	Hold	5,000	–	–	0.01%	924
2025 Q4	$280K	Hold	5,000	–	–	0.01%	951
2025 Q3	$315K	Hold	5,000	–	–	0.01%	913
2025 Q2	$285K	Hold	5,000	–	–	0.01%	877
2025 Q1	$280K	Buy	+5,000	New	+$300K	0.01%	851
2020 Q2	–	Sell	-4,900	Closed	-$461K	–	1402
2020 Q1	$461K	Sell	4,900 -5,000	-51%	-$465K	0.01%	800
2019 Q4	$1.07M	Sell	9,900 -4,000	-29%	-$405K	0.01%	720
2019 Q3	$1.33M	Hold	13,900	–	–	0.02%	645
2019 Q2	$1.33M	Hold	13,900	–	–	0.02%	649
2019 Q1	$1.23M	Sell	13,900 -3,000	-18%	-$264K	0.02%	685
2018 Q4	$1.4M	Sell	16,900 -3,000	-15%	-$264K	0.02%	617
2018 Q3	$1.88M	Sell	19,900 -2,600	-12%	-$248K	0.02%	658
2018 Q2	$2.48M	Hold	22,500	–	–	0.03%	552
2018 Q1	$2.22M	Sell	22,500 -3,050	-12%	-$272K	0.02%	551
2017 Q4	$2.08M	Sell	25,550 -2,450	-9%	-$191K	0.02%	589
2017 Q3	$2.06M	Sell	28,000 -6,000	-18%	-$432K	0.02%	589
2017 Q2	$2.46M	Buy	34,000 +100	+0.3%	+$6.58K	0.03%	512
2017 Q1	$2.11M	Hold	33,900	–	–	0.03%	555
2016 Q4	$2.47M	Sell	33,900 -2,000	-6%	-$130K	0.03%	500
2016 Q3	$2.15M	Sell	35,900 -50	-0.1%	-$3.18K	0.03%	510
2016 Q2	$2.27M	Buy	35,950 +50	+0.1%	+$3.23K	0.04%	472
2016 Q1	$2.25M	Sell	35,900 -400	-1%	-$23.6K	0.04%	476
2015 Q4	$2.13M	Hold	36,300	–	–	0.04%	480
2015 Q3	$1.96M	Hold	36,300	–	–	0.04%	494
2015 Q2	$2.17M	Hold	36,300	–	–	0.04%	484
2015 Q1	$2.17M	Hold	36,300	–	–	0.04%	495
2014 Q4	$2.18M	Hold	36,300	–	–	0.05%	487
2014 Q3	$1.77M	Hold	36,300	–	–	0.04%	531
2014 Q2	$1.87M	Hold	36,300	–	–	0.05%	531
2014 Q1	$2.1M	Hold	36,300	–	–	0.06%	478
2013 Q4	$2.08M	Sell	36,300 -50	-0.1%	-$2.74K	0.06%	461
2013 Q3	$2.16M	Buy	36,350 +50	+0.1%	+$2.73K	0.07%	390
2013 Q2	$1.97M	Buy	+36,300	New	+$1.71M	0.08%	341

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's UTMD Position: Q1 2026 in Review

Bridgeway Capital Management held its Utah Medical Products (UTMD) position steady in Q1 2026 at 5,000 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #924.

Bridgeway Capital Management first reported a position in UTMD in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.48M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Bridgeway Capital Management held 5,000 shares of Utah Medical Products worth $310K as of Q1 2026.
Bridgeway Capital Management left its Utah Medical Products share count unchanged in Q1 2026.
Utah Medical Products made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #924 holding.
Bridgeway Capital Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 33 quarters since.
Bridgeway Capital Management's Utah Medical Products position peaked at $2.48M in Q2 2018.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.